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Down-regulation of E-cadherin expression is a deter-
minant of tumor cell invasiveness, an event frequently
associated with epithelial-mesenchymal transitions.
Here we show that the mouse E12/E47 basic helix-loop-
helix transcription factor (the E2A gene product) acts as
a repressor of E-cadherin expression and triggers epi-
thelial-mesenchymal transitions. The mouse E47 factor
was isolated in a one-hybrid system designed to isolate
repressors of the mouse E-cadherin promoter. Epithelial
cells ectopically expressing E47 adopt a fibroblastic phe-
notype and acquire tumorigenic and migratory/invasive
properties, concomitant with the suppression of E-cad-
herin expression. Suppression of E-cadherin expression
under stable or inducible expression of E47 in epithelial
cells occurs at the transcriptional level and is depend-
ent on the E-boxes of the E-cadherin promoter. Interest-
ingly, analysis of endogenous E2A expression in murine
and human cell lines illustrated its presence in E-cad-
herin-deficient, invasive carcinoma cells but its absence
from epithelial cell lines. This expression pattern is con-
sistent with that observed in early mouse embryos,
where E2A mRNA is absent from epithelia but strongly
expressed in the mesoderm. These results implicate E12/
E47 as a repressor of E-cadherin expression during both
development and tumor progression and indicate its
involvement in the acquisition and/or maintenance of
the mesenchymal phenotype.
Invasion of tumor cells into adjacent connective tissues repre-
sents the first step of metastasis in carcinomas. The invasion
process involves the loss of cell-cell interactions together with the
gain of proteolytic and migratory properties and is frequently
associated with epithelial-mesenchymal transitions (EMTs)1 (1,
2), a crucial process for the generation of different tissues during
embryonic development (3). Strong cell-cell adhesion is mainly
dependent on the E-cadherin/catenin adhesion system in both
embryonic and adult epithelial tissues (4–7). Indeed, the loss of
E-cadherin-mediated intercellular interactions is required for the
acquisition of the invasive phenotype in epithelial tumors (8–10)
and for EMT processes that take place during early embryonic
development (5, 7). Therefore, characterization of the molecular
mechanisms that control E-cadherin down-regulation is of prime
importance for the understanding of both the tumor invasion
process and normal embryonic development.
Different mechanisms have been proposed to participate in the
silencing of E-cadherin expression during tumor progression,
including genetic and epigenetic alterations of the E-cadherin
locus (11–14) and changes in chromatin structure and transcrip-
tional regulation (15–18). With regard to the latter hypothesis,
previous studies on the mouse E-cadherin promoter have shown
that a palindromic element, E-pal, containing two adjacent E-
boxes, behaves as a strong repressor in E-cadherin-deficient car-
cinoma cells and fibroblasts (16, 19, 20).
Very recently, we have carried out a yeast one-hybrid screen-
ing to identify transcriptional repressors that interact with this
E-pal element leading to the identification of the zinc finger
transcription factor Snail as a direct repressor of E-cadherin
expression (21). Here, a second factor isolated in the same screen-
ing process is described which corresponds to the mouse bHLH
factor E47 (22–24). The E47 and E12 bHLH proteins are alter-
native splice products of the E2A gene (25), the founder member
of the vertebrate class I bHLH genes (22, 25–27). A large body of
evidence indicates that the E2A gene products play a central role
in tissue-specific gene regulation, usually after their dimeriza-
tion with tissue-specific class II bHLH proteins (28–31). Never-
theless, homodimers of E47 bHLH proteins are functionally
active in B-cell lineages where they participate in the transcrip-
tional regulation of several Ig genes (32). In fact the products of
E2A gene (E12/E47) are required for B-cell differentiation and Ig
gene rearrangements (33). In addition, targeted disruption of the
E2A gene leads to thymic lymphomas, suggesting that E2A gene
products can act as tumor suppressors (34, 35). The transcrip-
tional activity of E2A proteins can be negatively regulated by
their dimerization with another subclass of HLH factors, the Id
proteins (36). Additional class I bHLH members are coded by
independent genes such as HEB and E2-2 (37, 38). Gene knock-
out and knock-in analysis indicates that these gene products can
functionally cooperate with, or substitute for, E2A (39, 40).
Previous studies have shown that E12/E47 proteins are dis-
tributed widely in most adult tissues although at different
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levels of expression (26, 41). However, analysis of E12/E47 ex-
pression has not been undertaken in epithelial tissues or cell
lines. Using a combination of expression studies, band-shift as-
says, promoter analysis, and gain-of-function experiments in ep-
ithelial cells, evidence of a novel role for E12/E47 is provided
here. We show that E12/E47 participates in the repression of
E-cadherin expression and in the EMT process, leading to the
acquisition of invasive properties. These results further reinforce
the significance of transcriptional repression as a mechanism for
E-cadherin down-regulation during both development and tumor
progression.
EXPERIMENTAL PROCEDURES
Plasmid Constructs and One-hybrid Screening—The one-hybrid
screen designed to detect transcription factors interacting with the wild
type E-pal element of the E-cadherin promoter has been described
recently (21). 41 of the isolated clones carried cDNA inserts coding for
the mouse E47 bHLH transcription factor (22). The complete cDNA
sequence of E47 was subcloned into the pcDNA3 (Invitrogen) and the
pMT-CB6 vectors (42) under the control of the cytomegalovirus and the
sheep metallothionein I promoters, respectively.
Generation of Recombinant Proteins—The full cDNA coding sequence
of mouse E47 was amplified from the pACT2 vector using the following
primers: forward, 59-AGAATTCTGGATGATGAACC-39; reverse, 59-
ATACTCGAGGGCTCACAGG-39. The 1,972-bp product was then sub-
cloned into the pGEX4T1 vector (Amersham Pharmacia Biotech)
in-frame with the glutathione S-transferase (GST) protein. The se-
quence of the fusion construct was verified by automatic sequencing
from both ends and using several internal oligonucleotides covering the
full sequence. Production and purification of the recombinant GST-E47
protein were carried out following standard procedures.
Cell Culture and Generation of Tumors—The origin, tumorigenic
properties and expression of E-cadherin of the murine keratinocyte cell
lines MCA3D, PDV, HaCa4, and CarB have been described previously
(18, 20, 21, 43) and are summarized in Fig. 6b. Human cell lines derived
from differentiated colon carcinoma (HT29P), differentiated and dedif-
ferentiated mammary adenocarcinomas (MCF7 and MDA-MB435S),
bladder transitional cell carcinoma (T24), and melanomas (A375P) were
provided by Dr. A. Fabra (Institut de Recerca Oncologica, Barcelona,
Spain). The characteristics of these human cell lines have been de-
scribed previously (21) and are summarized in Fig. 6c. Cells were grown
in Dulbecco’s modified Eagle’s medium (CarB, MDCK-II and NIH3T3)
or Ham’s F-12 medium supplemented with a complete set of amino
acids (MCA3D, PDV, and HaCa4) or in Dulbecco’s modified Eagle’s
medium:Ham’s F-12 medium (1:1, Life Technologies, Inc) (human cell
lines) supplemented with 10 mg/ml insulin for the mammary cells.
Tumors were induced in athymic male nu/nu mice by subcutaneous
injection as described previously (21). Animals were obtained from the
animal production unit of IFA-CREDO factory (France) and maintained
in sterile conditions according to institutional guidelines. Injected ani-
mals were observed every 2 days and sacrificed when the tumors
reached a size of 1.5–2.0 cm, external diameter.
Stable Transfections—Transfections were carried out as described
recently (21) using the LipofectAMINE Plus reagent (Life Technologies,
Inc.). Stable transfectants were generated from MDCK cells after se-
lection with 400 mg/ml G418. Five and six independent clones were
isolated from pcDNA3-E47 and from control pcDNA3 transfections,
respectively. Stable transfectants were also generated from PDV cells
with the pMT-CB6-E47 vector and its corresponding control, also se-
lected with 400 mg/ml G418. PDV-pMT-CB6 stable transfectant clones
were grown in F-75 flasks to 40% confluence, and 100 mM ZnSO4 was
then added to the cultures to induce the expression of the metallothio-
nein I promoter. Cells were collected at the indicated times and ana-
lyzed for E-cadherin and E47 expression by RT-PCR.
RT-PCR Analysis—Poly (A)1 mRNA was isolated from the different
cell lines using Microfast Track isolation kit (Invitrogen). RT-PCR was
carried out as described previously (21). Mouse and human PCR prod-
ucts were obtained after 25–30 cycles of amplification with an anneal-
ing temperature of 65–70 °C. Primer sequences were as follows. For
mouse E-cadherin: forward, 59-CGTGATGAAGGTCTCAGCC-39; re-
verse, 59-ATGGGGGCTTCATTCAC-39 (amplifies a fragment of 616 bp).
For mouse E12/E47: forward, 59-TACCCCTCCGCCAAGACC-39; re-
verse, 59-TTGGGGGATAAGGCACTG-39 (amplifies a fragment of 412
bp). For canine E-cadherin (kindly provided by Y. Chen, Harvard Med-
ical School): forward, 59-GGAATCCTTGGAGGGATCCTC-39; reverse,
59-GTCGTCCTCGCCACCGCCGTACAT-39 (amplifies a fragment of 560
bp). For mouse and canine glyceraldehyde-3-phosphate dehydrogenase
(GAPDH): forward, 59-TGAAGGTCGGTGTGAACGGATTTGGC-39;
reverse, 59-CATGTAGGCCATGAGGTCCACCAC-39 (amplifies a frag-
ment of 900 bp). For mouse b-actin: forward, 59-TGGGCCGCTCTAG-
GCACC-39; reverse, 59-CTCTTTGATGTCACGCACG-39 (amplifies a
fragment of 540 bp).
E-cadherin Promoter Analysis—MDCK-mock and MDCK-E47 cells
were transiently transfected with 5 mg of the wt-178 construct, or the
mE-pal construct, fused to the chloramphenicol acetyltransferase (CAT)
reporter gene (16, 19) and 1 mg of the CMV-luciferase construct as a
control of transfection efficiency. The activity of SV40-CAT reporter
plasmid was also analyzed in parallel in each sample. CAT and lucif-
erase assays were performed as described previously (18, 20) with the
activity normalized to that of the wild type promoter detected in
MDCK-mock cells.
Nuclear Extracts and Band-shift Assays—Nuclear extracts from the
indicated cell lines were obtained as described previously (18, 20).
Band-shift assays with the 32P-labeled wild type E-pal or the mutant
E-pal probe were carried out with the recombinant GST-E47 protein or
nuclear extracts as described previously (20) but using the following
buffer: 25 mM Hepes, pH 7.9, 150 mM NaCl, 1 mM EDTA, 5 mM dithio-
threitol, 10% glycerol. Incubations were performed for 30 min at room
temperature. 1 mg of recombinant GST-E47 or GST control protein and
5 mg of nuclear extracts were used in the absence or presence of the
indicated competitors. For supershift assays, 5 mg of mouse monoclonal
Yae, or rabbit polyclonal anti-E2A antibody (E2A.E12, V-18) (Santa-
Cruz Biotechnology), was added to the reaction buffer and incubated for
15 min at room temperature before addition of the labeled wild type
E-pal probe.
Immunofluorescence and Western Blot Analysis—Staining for the
different markers was performed on methanol-fixed cells as described
previously (21). Preparations were visualized using a Zeiss Axiophot
microscope equipped with epifluorescence. Western blot analyses were
carried out on whole cell or nuclear extracts with the indicated anti-
bodies as described previously (21). For detection of E12/E47 protein in
murine cell lines and MDCK transfectant cells, the V-18 antiserum was
used (1:200 for immunostaining and 1:500 for Western), whereas in
human cell lines the mouse monoclonal Yae was used (1:2,000). The
anti-poly(ADP-ribose) polymerase (PARP) antiserum (1:500) (provided
by Dr. A. Lo´pez-Rivas, Instituto Lo´pez Neyra, Granada, Spain) was
used as a loading control for the nuclear extracts and the monoclonal
anti-a-tubulin N356 (Amersham Pharmacia Biotech) as a loading con-
trol of whole cell extracts.
Migration and Invasion Assays—Migration in wound assays and
invasion analysis on collagen type IV gels were carried out as described
previously (21).
In Situ Hybridization of Mouse Embryos—In situ hybridization anal-
yses of whole mount embryos and vibratome slices were performed as
described recently (21, 44). The mouse E2A probe corresponding to the
complete E47 cDNA sequence was used as a probe. The slices were
photographed with a Leica DMR microscope under Nomarski optics.
RESULTS
Mouse bHLH Factor E47 Interacts with the E-pal Element
in the E-cadherin Promoter—We have described recently a
one-hybrid yeast system designed to isolate transcriptional
repressors interacting with the E-pal element of the mouse
E-cadherin promoter. This screening led to the isolation of the
zinc finger transcription factor Snail and its characterization
as a strong repressor of E-cadherin expression (21). A second
factor isolated in high abundance (32% of the clones) in the
same screen showed identity with the reported C-terminal
sequence of mouse E47 cDNA (22). The full E47 cDNA (2,631
nucleotides), isolated in several clones, encodes an open read-
ing frame of 648 amino acids starting from a methionine at
nucleotide 133, which corresponds to the initiator methionine
identified in the human E12 protein (23). It also includes the
558 nucleotides of the 39-untranslated region. The deduced
amino acid sequence for mouse E47 shows high similarity with
the previously described partial amino acid sequences of the
mouse E47 protein (amino acids 1–153 and 323–478) (45) with
the unique exception of the absence of residue Gln-387, which
is also absent in the deduced amino acid sequences of the
human (23, 24) and rat (46) E12/E47 cDNAs. Other specific
E12/E47 and E-cadherin Repression 27425
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changes detected in the amino acid sequence of the full mouse
E47 protein were the insertion of two Ala residues (Ala-311,
Ala-312), the absence of Ala-168, present in the rat E47 isoform
(46), and the lack of several amino acid insertions uniquely
present in the human E12/E47 proteins (GSSS at 260, Ala-295,
His-510) (23, 24).
The specific binding of mouse E47 to the E-pal element of the
E-cadherin promoter detected in the yeast one-hybrid screen
was confirmed by band-shift assays using a recombinant fusion
protein, GST-E47. As shown in Fig. 1, GST-E47 interacts with
the wild type E-pal probe giving rise to two closely migrating
specific retarded complexes that are competed efficiently by the
unlabeled wild type probe but only partly competed by an
excess (3500 and 31,000) of the cold mutant E-pal probe (mE-
pal). An unrelated oligonucleotide corresponding to the
CCAAT-box of the E-cadherin promoter showed no competition
(data not shown). The apparent partial competition observed
with the mE-pal would suggest a weak interaction of the GST-
E47 protein with the mE-pal probe. However, no interaction of
GST-E47 protein could be detected in band-shift assays using
the mE-pal as labeled probe (Fig. 1, right lanes), indicating that
mutation of the two central nucleotides of the E-pal element
strongly decreases the binding affinity of the GST-E47 protein.
These results are consistent with the fact that the two point
mutations of the mE-pal probe abolish the two E2-boxes con-
sensus sequence (16, 21). They are also in agreement with the
observed binding in vivo of E47 in the yeast one-hybrid system.
Here, binding was detected for all E47 isolated clones in the
yeast strain carrying the selection gene (HIS3) under the con-
trol of the wild type E-pal element, but not in the corresponding
control yeast strain carrying the mutant E-pal (21). The bind-
ing specificity of GST-E47 to the E-pal probe was confirmed by
supershift assays using an anti-E2A antibody. The addition of
anti-E2A Yae monoclonal antibody led to the disappearance of
the major complexes and the appearance of a slowly migrating
supershifted complex (Fig. 1). These results indicate that
mouse E47 interacts with the E-pal element of the E-cadherin
promoter through the E2-boxes both in vivo in the yeast system
and in in vitro binding assays, supporting a role for E47 in the
transcriptional control of E-cadherin.
Stable Expression of E47 in MDCK Cells Represses E-cad-
herin Expression and Induces EMT and an Invasive Pheno-
type—To gain insights into the putative role of E47 in the
regulation of E-cadherin expression, gain-of-function studies
were performed in the prototypic epithelial cell line MDCK.
Cells were stably transfected with pcDNA3 (mock) or
pcDNA3-E47 (E47) vectors. Whereas no changes were observed
in the morphology of MDCK-mock transfectants, a dramatic
conversion to a fibroblastic phenotype was observed in five
independently isolated clones after transfection with the E47
expression vector (Fig. 2A, a and g). The cells apparently lost
all epithelial characteristics and acquired a spindle appear-
ance. This phenotypic change was associated with a loss of
E-cadherin expression (Fig. 2A, h), redistribution of other
epithelial markers such as plakoglobin (Fig. 2A, i) and desmo-
gleins (not shown), and increased organization of the mesen-
chymal markers vimentin (Fig. 2A, j) and fibronectin (Fig. 2A,
k). Ectopic expression of the E47 protein was observed in the
nuclei of the transfected cells (Fig. 2A, l). The qualitative
changes of the various markers observed by immunofluores-
cence were confirmed by Western blot analysis (Fig. 2B) of
whole cell extracts. This analysis confirmed the absence of
E-cadherin and an increase in levels of vimentin and fibronec-
tin in the E47-transfected cells. E47 mRNA transcripts were
detected in these cells by RT-PCR analysis (Fig. 2D), and West-
ern blot analysis of nuclear extracts (Fig. 2C) confirmed the
expression of a protein of relative molecular weight (Mr) 70,000
in MDCK-E47 transfectants, corresponding to the expected
size of the ectopic protein. Analysis of E-cadherin expression by
RT-PCR showed a complete absence of endogenous E-cadherin
transcripts in MDCK-E47 transfectant cells (Fig. 2D). These
results indicate that stable overexpression of E47 in MDCK
cells leads to the full repression of E-cadherin expression and
induces a dramatic EMT.
The process of EMT induced by overexpression of E47 in
MDCK cells prompted analyses of the migratory/invasive prop-
erties of control and E47-transfected cells. The migratory prop-
erties of the transfectants were first analyzed in a wound
culture assay (21) where MDCK-E47 cells showed a highly
migratory behavior, beginning to enter the wound after just 4 h
postincision (Fig. 3d). Approximately 70% of the wound surface
was colonized by E47-expressing cells 6 h after the wound was
made (Fig. 3f), whereas at this time the mock-transfected cells
had not yet started to migrate (Fig. 3e). The invasive properties
of the MDCK-E47 transfectants were analyzed further by in-
vasion assays in collagen type IV gels. In these experiments,
MDCK-E47 cells were able to invade and migrate through the
collagen gels (1.5% of the seeded cells emigrated through the
gel matrix and filter after 12 h), whereas mock-transfected cells
were not invasive at all. The tumorigenic properties of the
transfectants were analyzed by subcutaneous injection into
athymic nu/nu mice (Table I). MDCK-E47 cells gave rise to
tumors with a high growth rate at all injection sites (10 out of
10). 70% of the tumors induced by E47 transfectants reached
an external diameter of 1 cm 10–12 days postinjection with the
rest achieving this size 15 days postinjection. In fact, the tu-
mors induced by MDCK-E47 cells grew at a very high rate, and
the animals had to be sacrificed 18 days postinjection, when all
FIG. 1. The bHLH transcription factor E47 binds to the E-pal
element of E-cadherin promoter through the E2-boxes. Recombi-
nant GST and GST-E47 proteins (1 mg) were incubated with the 32P-
labeled wild type E-pal (Epal*) or mutant E-pal (mE-pal*) probe in the
absence or presence of the indicated cold probes used at 100-, 250-, 500-
and 1,000-fold molar excess or in the presence of 5 mg of anti-E2A Yae
mouse monoclonal or control mouse IgG. The retarded complexes de-
tected are indicated by an arrow and the supershifted complex by an
arrowhead. The complete sequence of the E-pal probe is indicated at the
bottom of the figure with the E2-boxes showed in black letters. The
specific nucleotides mutated in the mE-pal oligonucleotide are indicated
by asterisks and also shown in parentheses in the upper part of the
figure. The first 13 lanes from the left correspond to the samples incu-
bated with the Epal* probe and the last three lanes to those incubated
with the mEpal* probe, as indicated in the upper part of the figure.
E12/E47 and E-cadherin Repression27426
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tumors had reached an external diameter of 1.5–2.0 cm. These
results indicate that overexpression of the transcription factor
E47 induces an extremely aggressive tumorigenic and migra-
tory phenotype in MDCK cells.
E47 Represses E-cadherin Promoter Activity—E47 induces a
dramatic EMT in MDCK cells, an event associated with repres-
sion of E-cadherin expression (Fig. 2D). This suggests a role for
E47 in the down-regulation of E-cadherin promoter activity. To
extend these observations and to analyze directly its effect on
E-cadherin expression over time, the protein was transiently
expressed in the epidermal keratinocyte cell line PDV using an
inducible system in which E47 expression was driven by the
Zn21-inducible metallothionein promoter (Fig. 4a). Expression
of E47 mRNA started to be detected 6 h postinduction and
increased steadily up to 24 h followed by a slight decrease at
48 h. A small decrease in the endogenous E-cadherin mRNA
was observed 12 h after induction followed by a clear reduction
(60%) at 24 h and its complete disappearance 48 h
postinduction.
To support further the role of E47 as a repressor of E-
cadherin expression, the activity of an exogenous E-cadherin
proximal promoter was analyzed in mock- and E47-transfected
MDCK cells. As indicated in Fig. 4b, the wild-type promoter
construct exhibited a robust activity in MDCK-mock cells, sim-
ilar to that of a SV40-CAT control construct, whereas this
activity was almost undetectable in MDCK-E47 cells (3% of the
activity observed in MDCK-mock cells). The mutant construct
(mE-pal), in which the E2-boxes of the E-pal element are abol-
ished, showed 50% activity relative to that of the wild type
promoter in MDCK-mock cells. In contrast, this mE-pal con-
struct showed a 7.5-fold increase in activity over that of the
wild type promoter in MDCK-E47 cells (Fig. 4b). The activity of
the wild type and mE-pal constructs in MDCK-Snail transfec-
tant cells, reported recently (21), showed a behavior similar to
that of MDCK-E47 cells (data not shown), in agreement with
results reported previously in other E-cadherin-deficient dedi-
fferentiated carcinoma cells (16, 20). These results indicate
that transcriptional repressor(s) interact with the E-pal ele-
ment in E47-transfected cells. This was confirmed by band-
shift assays against the E-pal probe using nuclear extracts
obtained from MDCK-mock and MDCK-E47 cells. Two specific
retarded complexes of a similar intensity were detected in the
MDCK-E47 extracts (Fig. 5), which were competed efficiently
by the unlabeled probe but competed weakly by an excess of the
mE-pal probe. The partial competition observed with the mE-
pal oligonucleotide probably indicates the interaction of addi-
tional factors present in the nuclear extracts of MDCK-E47
cells with the E-pal element but apparently independent of the
E2-boxes. Addition of anti-E2A antiserum led to the total
disappearance of the slowest migrating complex and the ap-
pearance of a weak supershifted band. In contrast, very weak
complexes were detected when using the nuclear extracts from
FIG. 2. Stable transfection of E47 into MDCK cells induces an epithelial-mesenchymal conversion concomitant with a loss of
epithelial markers and the gain of mesenchymal markers. Panel A: a and g, phase-contrast images of living, subconfluent cultures of a
mock-transfected clone (a) and an E47-transfected clone (g); b–f, and h–l, immunofluorescence images of mock (b–f)- and E47-transfected (h–l) cells
showing the localization and organization of E-cadherin (b and h), plakoglobin (c and i), vimentin (d and j), fibronectin (e and k), and E2A (f and
l) proteins. Panels B and C, Western blot analysis of whole cell (B) and nuclear (C) extracts of the indicated proteins in mock- and E47-transfected
clones. Detection of nuclear PARP levels was used as a loading control for nuclear extracts. Panel D, the presence of E2A and E-cadherin transcripts
in mock- and E47-transfected clones was analyzed by RT-PCR. The expression of GAPDH was analyzed in the same samples as a control for the
amount of cDNA present in each sample. The 2RT lane shows the results of amplification in the absence of reverse transcriptase. Mock-transfected
cells apparently do not express endogenous E2A gene, and endogenous E-cadherin expression was repressed in E47-transfected clones.
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MDCK-mock cells (Fig. 5). The supershifts obtained after the
addition of anti-E2A antibodies to nuclear extracts from
MDCK-E47 cells are similar to those obtained from nuclear
extracts of diverse origins in which the disappearance of spe-
cific E2A complexes is detected easily, but the supershifted
complexes are frequently very weak (32, 47).
E12/E47 Factor Is Expressed in E-cadherin-deficient Cells
and in the Embryonic Mesoderm—Once demonstrated that ec-
topic expression of E47 is able to induce a dramatic phenotypic
change in prototypical epithelial cells in culture, we decided to
analyze the expression of E2A in a panel of mouse epidermal
keratinocyte cell lines which ranged from well differentiated
(MCA3D) to fully dedifferentiated spindle carcinoma cells
(CarB). These cell lines have been characterized previously
with regard to E-cadherin expression and tumorigenic and
invasive properties (43). The fibroblastic NIH3T3 cell line was
also included in the study. RT-PCR analysis (Fig. 6a) was
carried out using oligonucleotides designed to amplify a con-
served region between E47 and E12 transcripts. E2A tran-
scripts could be amplified from E-cadherin-deficient HaCa4
and CarB cells as well as from NIH3T3 fibroblasts, but not
from the E-cadherin-positive MCA3D and PDV cells. The ex-
pression of E12/E47 was confirmed by Western blot analysis of
nuclear extracts obtained from the different cell lines (Fig. 6b).
In agreement with RT-PCR results, E12/E47 protein could be
detected in HaCa4, CarB, and NIH3T3 cells but was absent in
MCA3D and PDV cells. To investigate further the relationship
between E-cadherin and E2A, the expression of both proteins
was analyzed in a panel of human carcinoma cell lines. The
carcinoma cell lines chosen include epithelial and dedifferenti-
ated cells derived from tumors of different etiologies, including
breast (MCF-7 and MDA-MB435S), colon (HT29P), and bladder
(T24) carcinomas, and melanomas (A375P cells), all of which
have been described previously (21). This latter analysis (Fig.
6c) confirmed the inverse correlation between E-cadherin and
E12/E47 in the human cell lines because significant levels of
E12/E47 protein were detected in E-cadherin-deficient MDA-
MB435S, A375P, and T24 cells, but the absence of E12/E47 was
observed in E-cadherin-positive MCF7 and HT29P cells (Fig.
6c). In addition, those murine and human carcinoma cell lines
that expressed E12/E47 showed invasive and metastatic prop-
erties (Fig. 6, b and c). The only exception to this was the
bladder transitional cell carcinoma T24 cell line, which shows
no invasive properties when analyzed on artificial gel matrixes,
although it does show down-regulated E-cadherin expression
(Fig. 6c) (21). However, E-cadherin down-regulation in T24
cells is caused by hypermethylation of the promoter (13), sug-
gesting that a distinct molecular mechanism is operating in
this case.
To explore the relationship between E-cadherin expression
and the distribution of E2A gene products in vivo, we analyzed
the expression of E12/E47 mRNA during early mouse devel-
opment. Previous studies have described the expression of the
rat homolog in sections of embryos (48) ranging from 12 to 18
days postcoitum. We have carried out in situ hybridization
analysis in whole mounted mouse embryos from 7.5 to 10.5
FIG. 3. E47 expression in epithelial cells induces a migratory
phenotype. The motility/migratory behavior of mock-transfected (a, c,
and e) and E47-transfected (b, d, and f) MDCK cells was analyzed in an
in vitro wound model. Confluent cultures of the mock clones and E47-
transfected clones were gently scratched with a pipette tip to produce a
wound. Photographs of the cultures were taken immediately after the
incision (a and b) and after 4 h (c and d) and 6 h (e and f) in culture.
TABLE I
Tumorigenicity of MDCK-E47 cells in nude mice
1 3 106 cells each of the indicated cell lines were injected subcuta-
neously into the two flanks of Balb/c nu/nu mice, and the animals were
checked every 2 days for the appearance of tumors.
Tumors/
injection
site
Latency to reach 1 cma
10–12 days 13–15
MDCK-mock 0/10 0/0 0/0
MDCK-E47 10/10 7/10 3/10
a The total number of tumors induced by the transfectants that had
reached an external diameter of 1 cm (latency) at the indicated days
after injection.
FIG. 4. E47 represses the activity of the E-cadherin promoter
in epithelial cell lines. Panel a, PDV clones obtained by stable trans-
fection with pMT-CB6 (Mock) and pMT-CB6-E47 (E47) were grown to
40% confluence, and 100 mM ZnS04 was then added to the cells in fresh
culture medium. Cells were collected at the time points indicated and
analyzed by RT-PCR for E-cadherin and E47 expression. The expres-
sion of GAPDH was analyzed in the same samples as a control for the
amount of cDNA present in each sample. Panel b, the activity of the
E-cadherin promoter is completely silenced in E47-expressing cells.
Mock-transfected and E47-transfected MDCK clones were transiently
transfected with the wild type (Wt-178; white bars) or mutant (mE-pal;
gray bars) E-cadherin promoter fused to the CAT reporter gene. Lucif-
erase and CAT activities were determined 24 h after transfection. The
activity of the promoter constructs is represented relative to that of the
wt-178 construct detected in the mock-transfected clone. Results rep-
resent the mean 1 S.D. of two independent experiments, each per-
formed with duplicate samples. The fold increase detected in the
mE-pal promoter activity relative to the wt-178 construct in E47-trans-
fected cells is indicated by a number above the error bar.
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days postcoitum with a full-length E47 probe, recognizing both
E47 and E12 mRNAs (Fig. 7). At the stages analyzed, expres-
sion is detected in many different tissues throughout the em-
bryo, but it is absent from the non-neural ectoderm (Fig. 7, c–f),
the heart primordium (Fig. 7b) and the extraembryonic mem-
branes except for the allantois (Fig. 7, a and b). The mesenchy-
mal distribution of E2A products was maintained in 10.5 days
postcoitum embryos, in which the complete absence of expres-
sion from the epithelia is clearly observed in vibratome sections
(Fig. 7, d–f). Interestingly, the expression of E-cadherin at the
same developmental stages follows an inverse pattern, being
absent from all mesodermal tissues and strongly expressed in
embryonic and extraembryonic epithelia regardless of their
origin (21). These results support the role of the E2A gene
products as repressors of E-cadherin expression and as factors
involved in the acquisition and/or maintenance of the mesen-
chymal phenotype.
DISCUSSION
Loss of E-cadherin mediated cell-cell adhesion is one of the
hallmarks of the invasion process which occurs during the
initial stages of the metastatic cascade. A large body of evi-
dence points to E-cadherin as an invasion suppressor gene.
This has stimulated investigation into the molecular mecha-
nisms responsible for E-cadherin down-regulation during tu-
mor progression. The recent identification of the transcription
factor Snail as a powerful direct repressor of E-cadherin ex-
pression in carcinoma cell lines (21, 49) has highlighted the
importance of transcriptional repression as a mechanism to
silence E-cadherin. Previous studies on the regulation of E-
cadherin by Snail indicate that during epithelial-mesenchymal
transitions the same molecules and regulatory mechanisms are
utilized for the same cellular processes during normal embry-
onic development and in pathological events in the adult such
as cancer progression (21). The results presented here demon-
strate that a second transcription factor, the class I bHLH
E12/E47 factor, coded by the E2A gene, is also involved in the
suppression of E-cadherin expression and in EMTs. The spe-
cific importance of E47, a member of a large family of bHLH
transcription factors which could potentially interact with the
E-pal element of the mouse E-cadherin promoter (31), was
initially highligthed by its identification in the one-hybrid
screen (41 out of 130 clones). Other bHLH factors were not
identified in this screen with the exception of a product of the
E2-2 gene which represented a much smaller proportion of the
isolated clones (to be reported elsewhere). The ability of E47 to
interact specifically with the E2-boxes of the E-pal element was
confirmed further in band-shift assays carried out both with a
recombinant E47 protein and with nuclear extracts of E47-
expressing cells. Interestingly, the products of E2A gene are
not expressed in epithelial cell lines, whereas they are strongly
expressed in E-cadherin-deficient, invasive cell lines. This ob-
servation is discrepant with the previous assumption that the
E2A gene is expressed ubiquitously (26, 33, 41). In relation to
this, the in situ hybridization analysis in mouse embryos
presented here clearly illustrates the absence of E2A gene
products in all embryonic epithelia, in contrast to its high
expression in the mesoderm of early embryos. The inverse
relationship observed between E2A and E-cadherin expression
in early embryonic development argues in favor of a role for
E2A gene products in the down-regulation of E-cadherin ex-
pression and thus in the generation and/or maintenance of the
FIG. 5. Endogenous bHLH protein E47 binds to the E-pal ele-
ment of the E-cadherin promoter through the E2-boxes. Nuclear
extracts of mock- and E47-transfected MDCK cells were analyzed in
band-shift assays. 5 mg of nuclear extracts from each sample was
incubated with the 32P-labeled E-pal probe in the absence or presence of
the indicated cold probes used at 500-fold molar excess or in the pres-
ence of 5 mg of anti-E2A antibody or control rabbit IgG. The retarded
complexes detected are indicated by arrows and the supershifted com-
plex by an arrowhead. The complete sequence of the E-pal probe and the
specific mutated nucleotides in the mE-pal oligonucleotide are as indi-
cated in Fig. 1. MDCK-E47 transfectants contain E2A-specific nuclear
complexes interacting with the E-pal element of the E-cadherin pro-
moter, whereas those complexes are absent or present in very low
amounts in epithelial MDCK-mock cells.
FIG. 6. Endogenous E2A factors are present in mouse and hu-
man invasive cell lines and in fibroblasts. Panel a, the expression
of E-cadherin and E2A was analyzed by RT-PCR in a panel of mouse
epidermal keratinocytes, ranging from well differentiated nontumori-
genic cells to dedifferentiated and highly aggressive spindle carcinoma
cells, and in NIH3T3 fibroblasts. The expression of b-actin was ana-
lyzed in the same samples as a control for the amount of cDNA present
in each sample. E2A mRNA products were amplified only in the cell
lines that showed repressed E-cadherin expression. Panel b, the inverse
correlation between E-cadherin and E2A expression in the murine cell
lines was also observed at the protein level. E-cadherin and E2A pro-
teins were detected by Western blot analysis of whole cell extracts (WE)
and nuclear extracts (NE) of the different cell lines, respectively. E12/
E47 proteins were detected at varying levels in the E-cadherin-deficient
cell lines. Panel c, the inverse correlation between E-cadherin and E2A
was also detected in human carcinoma cell lines of various etiologies.
Expression of E12/E47 was detected in E-cadherin-deficient A375,
MDA-MB435S, and T24 cells. Detection of PARP nuclear protein and
a-tubulin was used as a loading control for the amount of total protein
present in the nuclear extracts and whole cell extracts, respectively.
The morphology of the different cell lines in culture is indicated as: E,
epithelial; Ep, epithelioid; F, fibroblastoid. The invasive and metastatic
properties of the cell lines are indicated as 2 and 1 symbols; NT, not
tested. With exception of T24 cell line, expression of E12/E47 correlates
directly with the invasive properties of the murine and human cell
lines.
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mesenchymal phenotype. In this context, it is important to
consider that the lack of embryonic defects observed in E2A
null mice can probably be explained by functional complemen-
tation by E2–2 and HEB gene products (39, 40).
The involvement of E47 in EMTs and repression of E-cad-
herin expression is supported by ectopic expression studies in a
prototypic epithelial cell line. Stable expression of E47 in
MDCK cells induces a dramatic EMT, characterized by a com-
plete suppression of E-cadherin expression and an increased
expression and reorganization of mesenchymal markers. Sig-
nificantly, stable expression of E47 also leads to the acquisition
of migratory/invasive and tumorigenic properties in MDCK
cells. Additionally, in PDV cells, transient expression of E47
from an inducible expression vector causes a reduction in E-
cadherin expression (as observed by RT-PCR). These results,
together with the inverse correlation between the endogenous
E2A and E-cadherin expression in carcinoma cell lines and
embryos, support the hypothesis that E12/E47 participate in
the repression of E-cadherin expression. With regard to the
specific mechanism leading to the repression of E-cadherin by
E2A factor, our studies on the exogenous E-cadherin promoter
in MDCK-E47 cells, together with in vitro binding assays and
the in vivo yeast system, indicate a direct interaction of E47
with the E2-boxes of the E-pal element of the E-cadherin pro-
moter. Transcriptional regulation by E2A products is usually
mediated by specific heterodimers formed by their combination
with tissue-specific class II bHLH factors (25, 28–31). Thus, it
is likely that a specific bHLH partner cooperates with E47 in
the repression of E-cadherin expression. Potential partners for
E47 could be the mesodermal bHLH factors described in vari-
ous systems such as Twist (50), Meso1 (51), or Paraxis (52).
However, we cannot exclude the possibility that E47 ho-
modimers may be functionally active as E-cadherin repressors
because our band-shift assays using the recombinant E47 pro-
tein and the in vivo yeast analysis indicate that this factor is
able to interact with the E-pal element as an homodimer.
Finally, the data presented here do not exclude that repression
of the E-cadherin promoter by E12/E47 could also involve the
association with additional transcription factors. In this con-
text, it is relevant to mention that zinc finger factors such as
Snail (21, 49, 53), Slug (21, 54), or ZEB (55), some of which have
been characterized recently as E-cadherin repressors, also bind
to the E-boxes of the E-cadherin promoter. Alternatively, or in
addition, the repression mechanism of E12/E47 could also in-
volve its interaction with other coregulators in macromolecular
complexes, as has been described in the regulation of achute-
scute complex in Drosophila (56) and in genes involved in
hematopoiesis in erythroid cells (47). In any case, the interac-
tion of E12/E47 with putative specific bHLH partners and/or
additional regulators will ultimately depend on the cellular
context.
Because very recently we and others have demonstrated an
important role for the transcription factor Snail in the repres-
sion of E-cadherin expression (21, 49) and in the EMT events
that occur at tumor invasion and development (21), it is perti-
nent to compare these studies with the present report. Both
Snail and E47 are able to trigger EMT upon stable ectopic
expression in MDCK cells. However, a closer examination of
MDCK-E47 and MDCK-Snail transfectant cells reveals impor-
tant differences in their behavior. In particular, MDCK-E47
cells exhibited increased migration in wound assays, starting
to migrate into the wound much faster than MDCK-Snail cells
(see Fig. 3 and Ref. 21). In addition, the tumors induced by
MCDK-E47 cells show a higher rate of proliferation than those
induced by MDCK-Snail cells. These observations suggest that
although both factors are capable of triggering EMT and of
inducing an invasive and tumorigenic phenotype they may
operate in distinct aspects of these processes. Consequently, it
will be important to analyze and compare the influence of both
factors in other important tumor progression events, such as
angiogenesis.
With regard to their role in EMT during embryonic develop-
ment, the comparison of the expression patterns of Snail and
E2A in early mouse embryos shows that Snail is highly ex-
pressed in the regions undergoing EMTs (mainly the precursors
of the neural crest cells and the primitive streak) (21, 44),
whereas E2A transcripts are detected throughout the mesoderm
and the neural tube (Fig. 7). Interestingly, E2A transcripts are
detected only at very low levels in regions undergoing EMT such
as the neural crest cells delaminating from the neural tube (Fig.
7f), which show high levels of Snail expression (21, 44). In con-
trast, the expression pattern of Slug, another member of the
Snail family, overlaps with that of E2A (21, 44). As mentioned
above, Slug binds to the same E-boxes (54) as E47 and Snail,
making it a more likely candidate to cooperate with E47. Indeed,
Slug has been shown to participate in desmosome dissociation in
rat bladder epithelial cells (57) and suggested to cooperate with
Snail in the maintenance of the mesenchymal phenotype (21).
Because repression of E-cadherin occurs in regions undergoing
EMTs and it is maintained in the resulting mesenchyme (5, 21),
it could be postulated that Snail and E2A play distinct roles in
the repression of E-cadherin expression in embryonic develop-
FIG. 7. Expression of E2A in mouse
embryos. E2A is not expressed in embry-
onic epithelia. Whole mount in situ
hybridization of mouse embryos at 8.5
(panel a), 9 (panel b), and 9.5 days post-
coitum (dpc; panel c), and transverse vi-
bratome sections of 10.5 days postcoitum
embryos taken at the level of the posterior
(panels d and e) and anterior trunk (panel
f). E2A expression is detected in many
different tissues throughout the embryo
including the mesoderm and the neural
tube, but it is absent from the non-neural
epithelia (panels c–f), the heart primor-
dium (panel b), and the extraembryonic
membranes except for the allantois (panel
b). Note that the region of the neural tube
undergoing EMT (panel f, EMT zone) only
expresses low levels of E2A. a, amnion; al,
allantois; ba, branchial arch; e, ectoderm;
h, heart; nt, neural tube; s, somites.
E12/E47 and E-cadherin Repression27430
 at IN
STITU
TO
 D
E BIO
LO
G
IA
 FU
N
CIO
N
A
L Y
 G
EN
O
M
ICA
 CSIC on M
ay 20, 2016
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
ment. Snail may function by rapidly repressing E-cadherin ex-
pression at specific EMT sites, and E2A may then contribute to
the maintenance of this repression in the embryonic mesen-
chyme. It is tempting to speculate that a similar scenario could
operate during the invasion process in which the two transcrip-
tion factors could act in a coordinated or sequential action. Thus,
Snail could be responsible for the initial down-regulation of E-
cadherin expression at the invasion front while E2A, alone or in
cooperation with other repressors, could contribute to the main-
tenance of E-cadherin repression and the invasive mesenchymal
phenotype further away from the invasion front. Further studies
addressed to identify additional target genes for Snail and E2A
and their putative partners, together with a detailed analysis of
their expression patterns in tumor biopsies are needed to confirm
this hypothesis.
In summary, the results presented in this paper clearly show
a novel role for the bHLH transcription factor E12/E47 as a
repressor of E-cadherin expression and as an inducer of EMTs,
concomitant with the acquisition of an invasive phenotype.
They also reinforce the significance of transcriptional repres-
sion as a major mechanism involved in E-cadherin down-reg-
ulation. The next challenge will be the identification of specific
partners for E12/E47 which may cooperate in the regulation of
these important processes both during normal embryonic de-
velopment and in tumor progression.
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